What's Hot
View all perspectives
SKIPPAIN Trial: Dr. Sheila Reyes
Dr. Sheila Reyes reviews abstract #0899 presented at the 2020 ACR annual meeting.
Richard Conway RichardPAConway
4 years ago
Dr Lee reports on risk of melanoma and NMSC risk in RA in cohort study using propensity score matching. No difference in risk between MTX and HCQ overall. Increase BCC in MTX (HR 1.32) but less SCC (HR 0.77) @rheumnow #ACR20 Abstr#1001 https://t.co/LDWgfGK9LS
Dr. Rachel Tate uptoTate
4 years ago
5yr DESIR cohort data estimated incidence rate of uveitis at 1.3/100p-y; over five years, uveitis was associated w/ dactylitis, biologic and sacroiliac MRI inflammation. #ABS1304 #ACR20 @RheumNow https://t.co/qmXlY7PmBB
alexa meara lexmeara
4 years ago
Important thoughts- how do we actually use the biologics in practice for the rare diseases that do not have many FDA approved options? @RheumNow #ACR20 abstract 1429 https://t.co/SsYC1kF5uv
Dr. John Cush RheumNow
4 years ago
Shifting Treatment Paradigms in Psoriatic Arthritis: Dr. Eric Ruderman (@JointMD)
Chicago-based Dr. Eric Ruderman discussed the shifting treatment paradigms in psoriatic arthritis by reviewing abstracts #0504 and #2026 at #ACR20.
https://t.co/jsLkgWG63v https://t.co/h3r2oapOij
David Liew drdavidliew
4 years ago
Nintedanib in rheum ILD (RA/SSc/CTD)
I appreciate the volumes might not seem like much, but:
- in first 1y Rx 20% more are spared a FVC decline>10%
- biggest diff in UIP-like pattern
With the right patient selection, nintedanib does have its place!
#ACR20 ABST1048/1049 @RheumNow https://t.co/jGZdR84bBU
Mrinalini Dey DrMiniDey
4 years ago
Time-trends analysis of in-hospital mortality in #vasculitis in the US shows it to have significantly declined in this population from 1998 to 2014.
Abs#1423 #ACR20 @RheumNow
https://t.co/TTI4DJiCRk
Eric Dein ejdein1
4 years ago
Corkscrew hairs and swollen knee - what's your diagnosis? TM01 #ACR20 @RheumNow https://t.co/jOkI94AKr6
alexa meara lexmeara
4 years ago
Please take the new telemedicine survey- how can we help our patients during these unique times! @RheumNow #ACR20 https://t.co/n2jFfh1N9N
alexa meara lexmeara
4 years ago
So much more work to be done- the traditional tools for estimating CVD in rheumatic patients are likely not accurate especially patients with SLE- abstract 1286 @RheumNow #acr20 https://t.co/L6Z1fsO2he
Dr. Rachel Tate uptoTate
4 years ago
#ABS1303 shows ASAS modification of Berlin algorithm showed optimal balance between sensitivity and specificity and represented the preferred referral strategy for patients presenting w/ undiagnosed back pain & extra-articular features. #ACR20 @RheumNow https://t.co/10VdKC3E75 https://t.co/RgC7K3V8TB
Mrinalini Dey DrMiniDey
4 years ago
Patients diagnosed w/ #ANCA #vasculitis aged >75yrs have lower risk of relapse than pts 65-75yrs. Pts >75yrs less likely to be treated w/ immunosuppression & steroids but do benefit from this treatment when it is required.
Abs#1417 #ACR20 @RheumNow
https://t.co/stTAcioiQG
Eric Dein ejdein1
4 years ago
Excellent case - great job! @RheumNow #ACR20 #TM05 https://t.co/obE7KLD68m
Richard Conway RichardPAConway
4 years ago
Dr @AliDuarteMD presents on incidence of SLE over last 40 years, 29% increase overall, and doubled in males. Overall cyclical pattern. Abstr#1024 #ACR20 @rheumnow https://t.co/SSVY0U0SIg
Sole RetamozoSole
4 years ago
#sjogren #syndrome poster session #ACR20 @RheumNow Clinical characteristics: lung, pregnancy,smoking, cervical lesions, anti La, childhood. https://t.co/QN4FVvQrYN
Poster Hall